6505-00-961-7486 ( NDC00182-1543-64 , 0054619 , NDC00182-1543-64 , NDC00182-1543-64 , NDC00536-1970-72 , NDC00182-1543-64 , LIQUITEARS , TEARGEN , NDC00904-5017-35 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-00-961-7486 | 6505 | 009617486 | ARTIFICIAL TEARS SOLUTION | 3716 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| FEAT | SPECIAL FEATURES | IN PLASTIC DROPPER BOTTLE WITH OPHTHALMIC TIP; WITH SUITABLE PRESERVATIVE |
| CBBL | FEATURES PROVIDED | STERILE |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CSGS | ADMINISTRATION | OPHTHALMIC |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ARTIFICIAL TEARS SOLUTION 15 ML DROPPER BT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.400 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE, DROPPER |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 15.000 MILLILITERS |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00182-1543-64 | 1XUY5 | A | 1 | 3 | 4 | ZZ | |
| 0054619 | B6095 | A | 2 | 5 | 2 | ZB | |
| NDC00182-1543-64 | 00E55 | A | 1 | 3 | 4 | ZZ | |
| NDC00182-1543-64 | 63488 | A | 2 | 3 | 4 | KX | |
| NDC00536-1970-72 | 1UVZ2 | A | 2 | 3 | 4 | ZZ | |
| NDC00182-1543-64 | 0LXM4 | A | 2 | 3 | 4 | ZZ | |
| LIQUITEARS | 0SYT3 | A | 2 | 5 | 4 | ZZ | |
| TEARGEN | 1UVZ2 | A | 2 | 5 | 4 | ZZ | |
| NDC00904-5017-35 | 0SYT3 | A | 2 | 3 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00182-1543-64 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATI | F | A |
| 0054619 | B6095 | ASSOCIATION PHARMACEUTIQUE BELGE | F | A |
| NDC00182-1543-64 | 00E55 | CARDINAL HEALTH INC. | F | A |
| NDC00182-1543-64 | 63488 | GOLDLINE LABORATORIES INC. | A | A |
| NDC00536-1970-72 | 1UVZ2 | WATSON PHARMACEUTICALS INC. | A | A |
| NDC00182-1543-64 | 0LXM4 | IVAX | F | A |
| LIQUITEARS | 0SYT3 | MAJOR PHARMACEUTICALS INC | F | A |
| TEARGEN | 1UVZ2 | WATSON PHARMACEUTICALS INC. | A | A |
| NDC00904-5017-35 | 0SYT3 | MAJOR PHARMACEUTICALS INC | F | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 06/01/1 | P | 3004909185 | 3716 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DF | ------- | F | K | U/I CONTAINS 15 ML | |
| DM | Z | 1354--- | M | K | U/I CONTAINS 15 ML |
| DS | N | I | K | U/I CONTAINS 15 ML | |
| DA | C2201X- | A | K | U/I CONTAINS 15 ML | |
| VA | V | K | U/I CONTAINS 15 ML | ||
| DN | 9B----- | N | K | U/I CONTAINS 15 ML |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DA | SMS | L | 1 | BT | L | U | C2201X- | A | |
| DM | SMS | L | 1 | BT | L | U | Z | 1354--- | M |
| DS | SMS | L | 1 | BT | L | U | D | ||
| VA | I | 1 | BT | Q | U | V | |||
| DF | SMS | L | 1 | BT | L | U | ------- | F | |
| DN | SMS | L | 1 | BT | L | U | 9B----- | N |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 058770 | Z | 33400 | W | 532 | Z | 9 | A | M | Z | DRUGS/MEDICINES/VITAMINS NOI |